首页|新型冠状病毒感染疫苗的研究进展

新型冠状病毒感染疫苗的研究进展

扫码查看
新型冠状病毒感染(corona virus disease 2019,COVID-19)是由2019 冠状病毒病导致的急性呼吸道传染性疾病,在缺乏有效治疗的情况时,疫苗是预防和控制 COVID-19 的最有效和最具成本效益的策略。在立足于全球实际问题和对产品需求,比较COVID-19 疫苗开发利用的平台及发展阶段不同的基础上,着重对COVID-19 疫苗的安全性与有效性、不同种类疫苗的优势与劣势等方面进行分析。全球获得各国政府批准使用的新冠疫苗超过 25 款,我国已有 5 个品牌的新型冠状病毒疫苗获批上市。本文对新型冠状病毒感染疫苗的类型、研究成果等方面以及解决新型冠状病毒感染面临的挑战进行综述。
Progress in vaccine research for corona virus disease 2019
Novel coronavirus infection(coronavirus disease 2019,COVID-19)is an acute respiratory infectious disease caused by coronavirus disease 2019,and a vaccine is the most effective and cost-efficient strategy for preventing and controlling COVID-19 in the absence of effective treatment.Based on the actual global problems and the demand for products,this paper compares the different platforms and development stages of COVID-19 vaccine development and utilization,and focuses on the safety and effectiveness of COVID-19 vaccines,as well as the advantages and disadvantages of different types of vaccines.More than 25 COVID-19 vaccines have been approved for use by governments around the world,and five brands of COVID-19 vaccines have been approved for sale in China.This review introduces the types of vaccines for novel coronavirus infection,research achievements,as well as the challenges of novel coronavirus infection.

corona virus disease 2019corona virusvaccine

王蕊、王会岩、姜秀云

展开 >

吉林农业大学 生命科学学院,吉林 长春 130112

吉林医药学院 吉林省抗体工程协同创新中心,吉林 吉林 132013

新型冠状病毒感染 冠状病毒 疫苗

2024

沈阳药科大学学报
沈阳药科大学

沈阳药科大学学报

CSTPCD
影响因子:0.604
ISSN:1006-2858
年,卷(期):2024.41(12)